Grant of a FIT early loan of CHF 300’000
DBS Systema obtenuunprêt Early de 300’000francsde la Fondation…
Les tests sanguins à portée de main
Pourquoi prélever 10 mL de sang, quand on peut faire une analyse…
La FIT soutient deux entreprises dans le domaine des sciences de la vie
DBS System a obtenu un prêt Early de 300’000 francs. L’entreprise…
DBS System in the online newspaper Mergermarket
DBS System to raise up to CHF 12M to launch lab-on-chip device
for…
Interview with DBS Systems, the revolution in blood collection
9826 Comments
/
DBS System is a medtech startup founded in December 2010 and…
DBS System mentioned in the press release of "La Côte" of March 19th
Link to Article Source: http://goo.gl/66W6kh
Selected Companies for the Entente Life Sciences Investment Forum
The partners of the ENTENTE-project together with the European…
DISCLAIMER
HemaXis DB is a FDA Class 1 medical device. HemaXis DX is in development and for research purposes only. Use of HemaXis devices in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with local regulatory requirements.
By using this website you are agreeing to our Terms and Conditions.
CONTACT
DBS System SA
Rte des Avouillons 4
CH-1196 Gland
Switzerland
Tel: +41 (0) 78 624 70 15
Email: info@dbs-system.ch